SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation (ICU): 2 pipeline candidates · 3 clinical trials. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
N/A
D/E 0.54 · 0% dilution
Lead: Approved
2 candidates
N/A
N/A
A transparent, data-derived signal for SeaStar Medical Holding Corporationacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$12.2M
Cash
—
Quarterly Burn
$2.8M
Runway
—
Revenue
$495K
Pipeline (2 candidates)
| Drug | Phase |
|---|---|
| quelimmune | Approved |
| scd therapy | Phase 3 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
14
Total value held
$588K
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 57,582 | $214K |
| geode capital management, llc | 55,642 | $207K |
| jane street group, llc | 27,960 | $104K |
| vanguard fiduciary trust co | 13,692 | $51K |
| pnc financial services group, inc. | 1,748 | $7K |
| blackrock, inc. | 913 | $3K |
| osaic holdings, inc. | 230 | $854 |
| vanguard global advisers, llc | 165 | $614 |
| td waterhouse canada inc. | 22 | $78 |
| morgan stanley | 20 | $74 |
Showing top 10 of 14 institutional holders of SeaStar Medical Holding Corporation. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in SeaStar Medical Holding Corporation's pipeline?
SeaStar Medical Holding Corporation (ICU) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is SeaStar Medical Holding Corporation's lead drug candidate?
SeaStar Medical Holding Corporation's most advanced tracked candidate is quelimmune (Approved) for Pediatric patients with acute kidney injury (AKI) due to sepsis or a septic condition requiring kidney replacement therapy.
What is SeaStar Medical Holding Corporation's market capitalization?
SeaStar Medical Holding Corporation's market capitalization is approximately $12.2M.
Who is the CEO of SeaStar Medical Holding Corporation?
Mr. Eric Schlorff is the chief executive officer of SeaStar Medical Holding Corporation (ICU).
Get the full picture on SeaStar Medical Holding Corporation
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.